Drug
Remimazolam Tosilate
Remimazolam Tosilate: highest development phase Phase 3, developed by Jiangsu Hengrui Medicine. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| Remimazolam Tosilate NCT03779061 | Phase 3 | Sedation |
| Remimazolam Tosilate NCT03921775 | Phase 3 | Anesthesia for Elective Surgery Patients |
Latest
No recent events.
Follow Remimazolam Tosilate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.